Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.

Показать другие версии (1)

There is a growing recognition of the importance of protein kinases in the control of alternative splicing. To define the underlying regulatory mechanisms, highly selective inhibitors are needed. Here, we report the discovery and characterization of the dichloroindolyl enaminonitrile KH-CB19, a pote...

Полное описание

Библиографические подробности
Главные авторы:	Fedorov, O, Huber, K, Eisenreich, A, Filippakopoulos, P, King, O, Bullock, A, Szklarczyk, D, Jensen, L, Fabbro, D, Trappe, J, Rauch, U, Bracher, F, Knapp, S
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Схожие документы

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
по: Fedorov, O, и др.
Опубликовано: (2011)

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.
по: Huber, K, и др.
Опубликовано: (2012)

Regulation of influenza A virus mRNA splicing by CLK1
по: Artarini, A, и др.
Опубликовано: (2019)

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
по: Fernando Salvador, и др.
Опубликовано: (2018-05-01)

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
по: Maya L Bulos, и др.
Опубликовано: (2023-12-01)

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
по: Bullock, A, и др.
Опубликовано: (2009)

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation
по: Bullock, A, и др.
Опубликовано: (2009)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
по: Elizabeth Bowler, и др.
Опубликовано: (2018-04-01)

Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
по: Debdab, M, и др.
Опубликовано: (2011)

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
по: Kenichi Iwai, и др.
Опубликовано: (2018-05-01)

Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
по: Shinsuke Araki, и др.
Опубликовано: (2015-01-01)

DFG-1 residue controls inhibitor binding mode and affinity, providing a basis for rational design of kinase inhibitor selectivity
по: Schröder, M, и др.
Опубликовано: (2020)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family.
по: Filippakopoulos, P, и др.
Опубликовано: (2012)

Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
по: Filippakopoulos, P, и др.
Опубликовано: (2012)

Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes.
по: Pengfei Li, и др.
Опубликовано: (2013-01-01)

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
по: Vincent Geoghegan, и др.
Опубликовано: (2022-11-01)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
по: Viet Hung Dao, и др.
Опубликовано: (2021-10-01)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
по: Jasper Van Goubergen, и др.
Опубликовано: (2025-02-01)

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors.
по: Aiko Murai, и др.
Опубликовано: (2020-01-01)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
по: Walter, A, и др.
Опубликовано: (2018)

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
по: Ahmed K. ElHady, и др.
Опубликовано: (2021-02-01)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
по: Anne Walter, и др.
Опубликовано: (2018-01-01)

Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.
по: Selina Kern, и др.
Опубликовано: (2014-01-01)

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
по: Pogacic, V, и др.
Опубликовано: (2007)

CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
по: Tyler Funnell, и др.
Опубликовано: (2017-02-01)

Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.
по: Shamila S Gunatilleke, и др.
Опубликовано: (2012-01-01)

Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
по: Joanne Tan, и др.
Опубликовано: (2017-11-01)

CLK3 promotes tumor proliferation by activating MYC signaling
по: Jing Shen, и др.
Опубликовано: (2024-09-01)

Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
по: Lori Ferrins, и др.
Опубликовано: (2023-05-01)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
по: Popp, T, и др.
Опубликовано: (2016)

CLK2 Condensates Reorganize Nuclear Speckles and Induce Intron Retention
по: Bing Wang, и др.
Опубликовано: (2024-10-01)

Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors.
по: Christian Schmitt, и др.
Опубликовано: (2014-01-01)

The design and synthesis of 5-and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
по: Hay, D, и др.
Опубликовано: (2013)

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
по: Lori Ferrins, и др.
Опубликовано: (2023-10-01)

Discrimination of fennel chemotypes applying IR and Raman spectroscopy – discovery of a new -asarone chemotype
по: Krähmer, Andrea, и др.
Опубликовано: (2016-07-01)

Calculation of Splicing Potential from the Alternative Splicing Mutation Database
по: Afonin Kirill A, и др.
Опубликовано: (2008-02-01)

Developing small molecule inhibitors of the CREBBP bromodomain-histone interaction
по: Rooney, T, и др.
Опубликовано: (2012)

The Alternative Splicing Mutation Database: a hub for investigations of alternative splicing using mutational evidence
по: Afonin Kirill A, и др.
Опубликовано: (2008-02-01)

Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency
по: Subha Dahal, и др.
Опубликовано: (2022-08-01)

In depth investigation of the metabolism of Nectandra megapotamica chemotypes.
по: Katyuce de S Farias, и др.
Опубликовано: (2018-01-01)